What causes myotonic dystrophy type 2?
Fact-checked by Myotonic dystrophy type 2 (DM2) is a rare genetic condition caused by an unusually long stretch of repeated DNA letters in a gene called CNBP. This CNBP gene mutation leads to the production of abnormal RNA molecules that interfere with how cells process genetic information. Over time, this disruption can affect muscles and other parts of the body, leading to muscle weakness, stiffness, and other health problems.
Understanding what causes DM2 provides valuable clarity for long-term health management, as it is an inherited disorder affecting the muscles, heart, eyes, and endocrine system, which regulates hormones that control metabolism and other vital functions. Recognizing how this genetic change operates helps patients better understand their symptoms and partner effectively with their care team.
Whether individuals are evaluating symptoms for the first time or seeking answers after genetic testing, this guide explains how a CNBP gene change affects the body, how DM2 is inherited, and what a diagnosis means for relatives.
How does the DM2 gene change cause symptoms?
To understand what drives DM2, it helps to examine the DNA building blocks. DM2 is caused by an unusually large number of repeats of a short DNA sequence called CCTG in the CNBP gene. This is known as a repeat expansion. In people with DM2, the expanded region can contain approximately 75 to more than 11,000 CCTG repeats.
CNBP gene mutation and CCTG repeat expansion
Genes contain instructions that help cells make proteins and carry out essential functions. The CNBP gene provides instructions for making a protein called cellular nucleic acid-binding protein (CNBP), which helps cells process genetic information. A healthy CNBP gene normally contains a small number of CCTG repeats, which are made of four DNA building blocks: cytosine, cytosine, thymine, and guanine.
Toxic RNA and disrupted cell function
When cells read genes to make proteins, they first make an RNA molecule that can be processed to include only the relevant pieces of the gene that code for a protein. In DM2, cells transcribe the expanded DNA sequence in the CNBP gene into RNA that contains an abnormally long stretch of repeated genetic material. This RNA can fold into unusual shapes and trap proteins that normally help cells process RNA from other genes. As a result, cells can process other RNA molecules incorrectly, disrupting the production of proteins they need to function normally.
These cellular disruptions affect tissues throughout the body and contribute to symptoms associated with DM2, including:
- muscle weakness
- delayed muscle relaxation after contraction (myotonia)
- heart rhythm problems
- cataracts (clouding of the eye’s lens)
- hormone-related problems such as diabetes and thyroid dysfunction
How can DM2 be inherited?
DM2 follows an autosomal dominant inheritance pattern. This means the genetic change responsible for DM2 is located on non-sex chromosomes, so only one altered copy of the CNBP gene is required to cause the condition.
Individuals inherit two copies of most genes, one from each biological parent. When one copy of the CNBP gene carries the CCTG repeat expansion, the individual can develop DM2, even if the second copy does not carry the expansion.
Autosomal dominant inheritance
When a parent carries the genetic change for DM2, each child has a 50% chance of inheriting it. DM2 is almost fully penetrant, meaning nearly everyone who inherits the mutated gene develops symptoms during their lifetime. However, symptoms can be mild or remain unrecognized, and some individuals may die of unrelated causes before symptoms appear. Consequently, a person diagnosed with DM2 typically inherited the condition from a biological parent, even if that parent was never formally diagnosed.
Why symptoms vary within families
Symptoms and overall disease course often vary among affected family members because CCTG repeat expansion size does not reliably predict age of onset or clinical severity.
Some research suggests that other genetic factors might have a greater influence on how DM2 develops in different individuals. For example, variants in genes such as CLCN1 and SCN4A may act as genetic modifiers, intensifying features like myotonia and muscle pain, though researchers continue to investigate how these and other factors influence the condition.
Does repeat size predict DM2 severity?
Current evidence shows no clear correlation between the size of the CCTG repeat expansion and the severity of DM2. In other words, having a larger repeat expansion does not necessarily mean it will result in more severe symptoms.
How are the causes of DM1 and DM2 different?
DM1 and DM2 are both caused by abnormal repeat expansions, but the genetic changes occur in different genes and involve different DNA sequences.
Scroll horizontally to view all columns -->
| Characteristic | DM1 | DM2 |
| Affected gene | DMPK | CNBP |
| Repeat sequence | CTG | CCTG |
| Chromosome affected | Chromosome 19 | Chromosome 3 |
| Typical age of onset | Variable (birth to adulthood) | Usually adulthood |
| Symptom severity | Often more severe | Often milder |
The main difference is that a CTG repeat expansion in the DMPK gene causes DM1, whereas a CCTG repeat expansion in the CNBP gene causes DM2.
How is the DM2 gene change confirmed?
The genetic change that causes DM2 can be confirmed through genetic testing. The test looks for an abnormal expansion of the CCTG sequence in the CNBP gene, which is also known as ZNF9 or CNBP1.
What does a DM2 diagnosis mean for family?
Because DM2 is inherited, a confirmed diagnosis carries significant implications for biological relatives. As noted, each child of an affected individual has a 50% chance of inheriting the genetic alteration that causes the condition.
A diagnosis also indicates that other family members may carry the same mutation, even if they experience mild symptoms or remain asymptomatic. Genetic testing can identify which relatives carry the expansion.
A genetic counselor can help families evaluate inheritance risks, discuss whether genetic testing may be appropriate for certain relatives, provide guidance on family planning, and offer emotional support throughout the decision-making process.
Muscular Dystrophy News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
